| Literature DB >> 23043518 |
Charlotte Warren-Gash1, Ellen Fragaszy, Andrew C Hayward.
Abstract
Hand hygiene may be associated with modest protection against some acute respiratory tract infections, but its specific role in influenza transmission in different settings is unclear. We aimed to review evidence that improving hand hygiene reduces primary and secondary transmission of (i) influenza and (ii) acute respiratory tract infections in community settings. We searched Medline, Embase, Global Health and Cochrane databases up to 13 February 2012 for reports in any language of original research investigating the effect of hand hygiene on influenza or acute respiratory tract infection where aetiology was unspecified in community settings including institutions such as schools, and domestic residences. Data were presented and quality rated across outcomes according to the Grading of Recommendations Assessment, Development and Evaluation system. Sixteen articles met inclusion criteria. There was moderate to low-quality evidence of a reduction in both influenza and respiratory tract infection with hand hygiene interventions in schools, greatest in a lower-middle-income setting. There was high-quality evidence of a small reduction in respiratory infection in childcare settings. There was high-quality evidence for a large reduction in respiratory infection with a hand hygiene intervention in squatter settlements in a low-income setting. There was moderate- to high-quality evidence of no effect on secondary transmission of influenza in households that had already experienced an index case. While hand hygiene interventions have potential to reduce transmission of influenza and acute respiratory tract infections, their effectiveness varies depending on setting, context and compliance.Entities:
Keywords: Acute respiratory tract infection; hand hygiene; influenza; systematic review
Mesh:
Year: 2012 PMID: 23043518 PMCID: PMC5781206 DOI: 10.1111/irv.12015
Source DB: PubMed Journal: Influenza Other Respir Viruses ISSN: 1750-2640 Impact factor: 4.380
Effect of hand hygiene on laboratory‐confirmed influenza
| Description | Risk or rate of illness | Relative effect (95% CI) | Quality of evidence | |||
|---|---|---|---|---|---|---|
| No. of studies | Design | Setting | Hand hygiene | Control | ||
| Influenza attack rate in schools [follow‐up mean 131 days; assessed with: RT‐PCR (1 study) or QuickVue antigen detection test (1 study)] | ||||||
| 2 | Randomised cluster trials | Schools
Egypt | Influenza rate
=125/250 584 child weeks
=51/42 375 child weeks
| Influenza rate
=281/282 832 child weeks
=53/41 625 child weeks
| RR 0·50 (0·38–0·66†) RR 0·81 (0·54–1·23)a | ⊕⊕⊕O Moderate‐qualityb evidence of effect in lower–middle‐income setting |
| Influenza H1N1 seropositivity in community (assessed with: Haemagglutinin inhibition assay titre ≥40) | ||||||
| 1 | Case–control study | Serological survey, various settings
China | Raw data not shown
| Raw data not shown
| OR 0·21 (0·06–0·74) | ⊕⊕OO Low‐qualityc evidence of effect |
| Influenza attack rate in households (follow‐up 19 months; assessed with: RT‐PCR) | ||||||
| 1 | Randomised cluster trial | Households
USA | Influenza rate
=0·60/1000 person weeks
| Influenza rate
=0·52/1000 person weeks
| RR 1·15 (0·57–2·32†) | ⊕⊕OO Low‐qualityd evidence of no effect |
| Risk of secondary influenza transmission in households (follow‐up mean 381·5 days; assessed with: RT‐PCR or serology (4‐fold rise in HI titre in paired samples)e | ||||||
| 2 | Randomised cluster trials | Households
Hong Kong | Secondary influenza risk
=14/257 (5·4%)
=66/292 (22·6%)
| Secondary influenza risk
=28/279 (10·0%)
=58/302 (19·2%)
| OR 0·57 (0·26–1·22)f OR 1·20 (0·76–1·88) | ⊕⊕⊕O Moderate‐qualityg evidence of no effect on secondary transmission |
RR (95% confidence intervals†) denotes confidence intervals calculated according to formulae in Appendix S1 and adjusted for clustering by multiplying standard error by square root of design effect.
aIn subgroup analysis in one study, there was a significantly lower incidence of influenza A in the intervention group: adjusted IRR = 0·48 (95% CI 0·26–0·87) but not for influenza B: adjusted IRR = 1·45 (95% CI 0·79–2·67).
bOutcome rated ‘moderate quality’ due to serious risk of bias associated with low rates of influenza testing which may have been differential across intervention and control groups: in one study, only 34% of school absences had a reason given (so many ILIs may have been missed) and up to 24% of ILIs identified were not tested for influenza. In a second study, only 33% and 47% of ILIs in the control and intervention groups, respectively were tested for influenza. Also despite randomisation, there were significant differences in baseline characteristics between groups in one study.
cOutcome rated ‘low quality’ as evidence is from an observational study with a risk of selection bias as only half of potential cases were included due to lack of contact information. Also the exposure ‘frequent hand washing’ was not defined, and there was little description of control for confounding.
dOutcome rated ‘low quality’ due to imprecision (small number of cases) and serious risk of bias. Risk of bias was due to loss to follow‐up: 17·5% of households were not contactable after randomisation, some baseline imbalances between groups, differential reporting of weekly illnesses between intervention and control groups and recording of outcomes was sometimes unclear, for example, groups combined for influenza/ILI/ARI in some analyses.
eOne study used RT‐PCR alone for influenza diagnosis. The other study which used both RT‐PCR and paired serum samples to detect a fourfold rise in HI titre identified 309 cases (90%) by RT‐PCR and an additional 34 (10%) by serology testing.
fIn Subgroup analysis in one study, where the intervention was applied within 36 hours of diagnosis of the index case, the odds ratio for influenza among contacts was 0·46 (95% CI 0·15–1·43). In the other study, where the intervention was applied within 48 hours of diagnosis of the index case, the odds ratio for influenza among contacts was 1·06 (95% CI 0·62–1·82).
gOutcome rated ‘moderate quality’ due to imprecision (both studies underpowered as did not reach recruitment goals). ,
RR, rate ratio. OR, odds ratio.
Effect of hand hygiene on acute respiratory tract infection including influenza‐like illness
| Description | Risk or rate of illness | Relative effect (95% CI) | Quality of evidence | |||
|---|---|---|---|---|---|---|
| No. of studies | Design | Setting | Hand hygiene | Control | ||
| ILI absence rate in schools [follow‐up mean 131 days; assessed with CDC definition (fever plus either cough or sore throat)] | ||||||
| 2 | Randomised cluster trials | Schools
Egypt | ILI absence rate
=917/250 584 child weeks
=171/42 375 child weeks
| ILI absence rate
=1671/282 832 child weeks
=190/41 625 child weeks
| RR 0·62 (0·49–0·78†) RR 0·86 (0·60–1·22) | ⊕⊕⊕Ο Moderate‐qualitya evidence of effect in lower–middle‐income setting |
| Respiratory absence in schools (follow‐up mean 47 days; assessed with reason for absence given as symptoms including cough, sneeze, sinus trouble, bronchitis, fever alone, pink eye, headache, mononucleosis and acute exacerbation of asthma) | ||||||
| 3 | 2 Non‐randomised cluster trials 1 non‐randomised crossover trial | Schools
USA (i) | Respiratory absence rate
=69/9615 child days
=64/5172 child days
=31/8292 child days
| Respiratory absence rate
=101/9459 child days
=70/5836 child days
=62/8260 child days
|
| ⊕⊕ΟΟ Low‐qualityb evidence of effect |
| Upper respiratory tract infection rate in childcare centres [follow‐up 275 days; assessed with two of the following symptoms for 1 day or one symptom (excluding cough) for 2 days: runny nose, blocked nose, cough] | ||||||
| 1 | Randomised cluster trial | Child care centres
Australia | URI incidence rate
=1716/62 159 child days
| URI incidence rate
=1547/51 518 child days
| RR 0·95 (0·89–1·01) | ⊕⊕⊕⊕ High‐quality evidence of marginal effectc |
| Sore throat or cold in childcare centres (follow‐up 2 months post‐intervention; assessed with symptoms reported by parent or teacher but no definition given) | ||||||
| 1 | Randomised cluster trial | Child care centres
Denmark | Illness risk
=29/212 children (13·7%)
| Illness risk
=45/263 children (17·1%)
|
| ⊕⊕ΟΟ Low‐qualityd evidence of no effect |
| Upper respiratory tract infection rate in elderly day care centres (follow‐up 4 months; assessed with nasal congestion, sore throat, new or increased cough, wheeze, sputum production or respiratory difficulty with or without fever) | ||||||
| 1 | Non‐randomised crossover trial | Elderly day care centres
USA | Illness rate
=8·27/100 person months
| Illness rate
=7·04/100 person months
|
| ⊕⊕ΟΟ Low‐qualitye evidence of no effect |
| Risk of common cold in the workplace (follow‐up 426 days; assessed with reporting of ‘cold’ but no definition given) | ||||||
| 1 | Randomised controlled trial | Office
Germany | Cold risk
=27/64 participants (42·2%)
| Cold risk
=44/65 participants (67·7%)
| OR 0·35 (0·17–0·71) | ⊕⊕ΟΟ Low‐qualityf evidence of effect |
| Upper respiratory tract infection risk in student halls of residence (follow‐up 8 weeks; assessed with two or more of the following, one of which must last at least 2–3 days: sore throat, stuffy nose, ear pain, painful/swollen neck, cough, chest congestion, sinus pain, fever) | ||||||
| 1 | Non‐randomised cluster trial | Student halls of residence
USA | Illness risk
=70/188 participants (37·2%)
| Illness risk
=94/203 participants (46·5%)
|
| ⊕⊕ΟΟ Low‐qualityg evidence of no effect |
| Rates of cough or difficulty breathing in under 15s in squatter settlements [follow‐up 355 days; assessed with parent‐reported cough or difficulty breathing in the last week. For under 5s, pneumonia diagnosed if raised respiratory rate present above WHO thresholds (>60 if under 60 days old, >50 if aged 60–364 days, >40 if aged 1–5 years)] | ||||||
| 1 | Randomised cluster trial | Households in squatter settlements Pakistan | Illness incidence rate = 4·16/100 person weeks | Illness incidence rate = 8·50/100 person weeks
| RR 0·49 (0·35–0·63) | ⊕⊕⊕⊕ High‐quality evidence of effect in low‐income setting |
| ILI attack rate in households [follow‐up 19 months; assessed with CDC definition (fever plus either cough or sore throat)] | ||||||
| 1 | Randomised cluster trial | Households USA | ILI rate = 2·52/1000 person weeks
| ILI rate = 2·77/1000 person weeks
| RR 0·91 (0·69–1·20†) | ⊕⊕ΟΟ Low‐qualityh evidence of no effect |
| Risk of secondary ILI transmission in households [follow‐up mean 381·5 days; assessed with CDC definition (fever plus either cough or sore throat) for all except children under 2 years in one study for whom definition was fever plus one of nasal discharge/congestion, cough, conjunctivitis, respiratory distress, sore throat and new seizure] | ||||||
| 2 | Randomised cluster trials | Households
Hong Kong | Secondary ILI risk
=9/257 participants (3·5%)
=50/292 participants (17·1%)
| Secondary ILI risk
=14/279 participants (5·0%)
=26/302 participants (8·6%)
| OR 0·81 (0·33–2·00) OR 2·09 (1·25–3·50) | ⊕⊕⊕Ο Moderate‐qualityi evidence of no effect on secondary transmission |
| Upper respiratory tract infection secondary transmission rate in households [follow‐up 181 days; assessed with two of the following symptoms for 1 day or one symptom (excluding cough) for 2 days: runny nose, stuffy/blocked nose, cough, fever/chills, sore throat, sneezing] | ||||||
| 1 | Randomised cluster trial | Households
USA | Secondary URI rate
=241/9648 person days
| Secondary URI rate
=202/8525 person days
| RR 0·97 (0·72–1·30) | ⊕⊕⊕⊕ High‐quality evidence of no effect on secondary transmission |
RR (95% confidence intervals†) denotes confidence intervals calculated according to formulae in Appendix S1 and adjusted for clustering by multiplying standard error by square root of design effect.
RR (95% confidence intervals) denotes confidence intervals calculated according to formulae in Appendix S1 but unadjusted for clustering.
aOutcome rated ‘moderate quality’ due to serious risk of bias from incomplete ascertainment of outcome (reasons for absence given for only 34% of illnesses in one study and proportion not reported – but appears low – in the other study ).
bOutcome rated ‘low quality’ due to very serious risks of bias across all studies from lack of randomisation, loose‐case definition, lack of intention to treat analysis (one study ), lack of control for clustering, risk of contamination of the intervention across groups in the crossover study and no assessment of compliance with intervention.
cEffect described as ‘marginal’ because although only a small effect that just failed to reach statistical significance in multivariable analysis was seen, significant results were presented for various subgroups including children aged under 24 months [RR 0·90 (0·83–0·97)] and those who complied best with the hand hygiene intervention [RR 0·89 (0·82–0·97)].
dOutcome rated ‘low quality’ due to imprecision (small numbers of illnesses) and serious risk of bias. Risk of bias was due to unclear reporting of loss to follow‐up, lack of case definition, absence of statistical analysis, no control for clustering or repeated episodes of illness.
eOutcome rated ‘low quality’ due to imprecision (small number of illnesses) and very serious risks of bias from insufficient number of clusters, lack of randomisation, lack of control for clustering, risk of contamination between periods on and off the intervention, unclear reporting of outcomes and loss to follow‐up. NB Rate ratio and confidence intervals calculated from numbers in this table of publication, not rates given in text.
fOutcome rated ‘low quality’ due to imprecision (small number of participants) and serious risk of bias. Risk of bias was due to low initial response rate (15·8%), baseline imbalance between groups (more females in intervention group) and no accounting for multiple episodes of illness in analysis.
gOutcome rated ‘low quality’ due to very serious risks of bias from lack of randomisation, insufficient number of clusters, loss to follow‐up, unclear reporting of outcomes, lack of control for clustering or repeated episodes of illness.
hOutcome rated ‘low quality’ due to imprecision (sample size calculation assumes much larger rate of illness than found) and serious risk of bias. Risk of bias was due to differential completing of illness surveys in intervention and control groups, some baseline imbalances between groups, loss to follow‐up and unclear reporting of outcomes.
iOutcome rated ‘moderate quality’ due to imprecision (both studies had small numbers of illnesses and neither reached recruitment goals).
RR, rate ratio or risk ratio depending on effect measure presented. OR, odds ratio.
Figure 1Flowchart of studies. *Studies were published between 1997 and 2011 and included nine cluster randomized trials, four non‐randomized cluster trials, one crossover intervention trial, one individually randomised controlled trial and one matched case control study. ±Of the three articles not identified through database searches, two had a main outcome of ‘illness absenteeism’, , with respiratory illness as a subgroup and the third was a Danish article with the outcome described as ‘sickness’ in the limited English translation available online.
Figure 2Effect of hand hygiene on influenza and acute respiratory infection in different settings. (A) Laboratory‐confirmed influenza outcomes. (B) Acute respiratory infection outcomes.